You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Air Launch Testbed for Endoatmospheric Hypersonic Trajectories

    SBC: GENERATION ORBIT LAUNCH SERVICES, INC.            Topic: AF141081

    The scope of this work includes design, analysis, manufacturing, integration, and test of the GO1 hypersonic flight test platform. The Contractor shall complete design of the system, qualify the system for flight through ground testing, and validate the f

    SBIR Phase II 2017 Department of DefenseAir Force
  2. Phase 1 Clinical Evaluation of NP10679, a GluN2B Selective,Context-Dependent NMDA Receptor Inhibitor for Subarachnoid Hemorrhage

    SBC: NEUROP, INC.            Topic: 102

    Abstract Subarachnoid hemorrhageSAHremains a serious source of neurological morbiditywith approximatelycases reported in the US each yearDespite advances in treating the initial and subsequent bleedspost surgical clipping of the aneurysm is associated with a significant risk of delayed cerebral ischemiaDCIThese events typically occur within the firstdays after aneurysmal rupture and DCI remains th ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Advanced therapeutic for Parkinson's Disease

    SBC: Inhibikase Therapeutics, Inc.            Topic: 105

    Parkinson s DiseasePDis a progressive neurodegenerative disorder that affectsmillion patient in the U Sannually andtomillion people worldwidePD is characterized by disorders of movementwhich are caused by the progressive loss of dopamine neurons in the substantia nigra pars compactaSNpcand autonomic dysfunctionanxietydepressionsleep disorders and cognitive impairment that are due to the degenerati ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II

    SBC: MBC Pharma, Inc.            Topic: NCI

    Project Summary AbstractThe overall aim of this project is to further develop a novel gemcitabine ibandronate conjugate alone and or as part of a combination therapy for the treatment of osteosarcoma and associated metastasesThe conjugate consists of chemically linked anticancer antimetabolite Gemcitabine and the bone homing bisphosphonate IbandronateThe novel conjugate directly addresses the limi ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis

    SBC: INLIGHTA BIOSCIENCES L.L.C.            Topic: 102

    Abstract The liver is the most common organ for metastasis of various cancersincluding pancreaticovariancolorectalgastric cancers and melanomaUveal melanoma metastasizes inof patients and upon metastasis targets the liver inof these casesThe most common primary malignant liver cancer worldwide is hepatocellular carcinomaHCCThe use of blind liver biopsy as a diagnostic tool for liver cancer has man ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Advanced PML antiviral

    SBC: Inhibikase Therapeutics, Inc.            Topic: NIAID

    Inhibikase Therapeutics is a clinical stagebiopharmaceutical company that has developed a hosttargeted mechanism of action to treat AIDS related and drug induced progressive multifocal leukoencephalopathyPMLPML is a demyelinating disease of the central nervous system and was rarely seen clinically until the era of the HIV epidemic began in the midsDuring the height of the epidemicthe rate of PML o ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  7. IND enabling studies for a personalized immunotherapy for triple negative breast cancer

    SBC: METACLIPSE THERAPEUTICS CORP            Topic: NCI

    Abstract The worldwide incidence of breast cancer ismillionTriple negative breast cancersTNBCaccount forof total breast cancer casesworldwideAnnuallyovernew cases of TNBC are diagnosed in the US aloneThe treatment options for TNBC patients are limitedTriple negative breast cancerTNBCincludes breast cancers that lack estrogen receptorprogesterone receptorand HERproteinsLack of known targets and pat ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Thermal Management of Highly Integrated Radio Frequency (RF) Electronics

    SBC: FIRST RF CORPORATION            Topic: N111023

    Sophisticated radar antennas such as an active electronically scanned aperture (AESA) are used to support acquisition and tracking in multiple modes over wide bandwidths, monopulse tracking, and Sense and Avoid RADAR (SAA) for UAV applications. These multi-function radar systems are small but require a considerable amount of power, which in turn produces a significant amount of heat. For these sys ...

    SBIR Phase II 2017 Department of DefenseNavy
  9. Micropatterned surfaces for minimizing pediatric gastrostomy tube complications

    SBC: Sharklet Technologies Inc.            Topic: NICHD

    Summary In a variety of diseases and conditions when oral feeding is impossibleenteral feeding through percutaneous gastrostomyPGis necessary to provide long term nutrition for adult and pediatric patientsIt is estimated that overthousand feeding tubes are placed in pediatric patients in the US annuallyHoweverthese patients frequently experience complications associated with PG tube placementLate ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Research in Tool Shape Optimization for Electrochemical Machining

    SBC: Corrdesa, LLC            Topic: A16013

    The ability to accurately machine nickel-based alloys and other hard materials is critical to the manufacture of Army weapons such as mortar tubes, and electrochemical machining (ECM) is often the best, or only, option. The primary drawback of ECM is designing ECM tools. Tool design is extremely complex because the shape of the machined workpiece depends on tool shape, electrolyte and material ele ...

    SBIR Phase II 2017 Department of DefenseArmy
US Flag An Official Website of the United States Government